News

Forbion, a life sciences venture capital firm, has held a first close on €75m for Forbion BioEconomy Fund I, which is targeting €150m.

Dutch venture capital firm Lumo Labs has raised €100 million for its newest fund, Lumo Rise Fund, which will invest in European start-ups focused on emerging digital technologies for a greener society.

Sovereign’s Capital has closed on more than $60 million for its fourth venture capital fund, which will invest in "faith-driven teams" in the US and Southeast Asia.

Index Ventures has raised $800 million for its 12th venture fund and $1.5 billion for its seventh growth fund.

J2 Ventures, a Boston-based deep tech venture firm, has raised $150 million for its second fund, beating its target by $30 million.

Private capital has started flowing towards climate finance, but is unevenly spread across strategies and sectors, leaving a growth equity 'missing middle,' says a new CREO report.

The convoluted structure of the healthcare industry and unique challenges of technology adoption give VCs with experience as clinicians and operators an advantage, says Zoi Capital co-founder Dr. Ronald Razmi.

Since HNWIs have 'a larger share of their wallet in cash or public equity that trades at all-time highs, they have ample liquidity to commit to private equity,' says co-founder and CEO Jacqueline van den Ende.

About 20% of Industry Ventures Partnership Holding VII will be dedicated to purchasing LP stakes in venture funds, says senior managing director Roland Reynolds.

New and existing VC secondaries players have raised billions in fresh capital as liquidity needs show no signs of slowing.